Propranolol and exercise as a screening test for growth hormone deficiency

Area of Science:

• Pediatric Endocrinology
• Diagnostic Testing
• Hormone Assays

Background:

• Accurate assessment of growth hormone (GH) reserve is crucial for diagnosing growth disorders in children.
• Traditional screening tests, like exercise stimulation, often yield false-negative results in non-GH-deficient individuals, limiting their reliability.
• There is a clinical need for a safe, inexpensive, and dependable screening method for GH reserve.

Purpose of the Study:

• To evaluate the efficacy of combining beta-adrenergic blockade (propranolol) with exercise as a screening test for growth hormone (GH) reserve.
• To determine if this combined stimulus can overcome the limitations of exercise alone in eliciting adequate GH release.

Main Methods:

• A cohort of 32 non-GH-deficient children and 5 GH-deficient children underwent testing.
• The study utilized a combined stimulation protocol involving propranolol administration followed by exercise.
• Serum GH levels were measured to assess the response to the combined stimulus.

Main Results:

• All 32 non-GH-deficient children exhibited a significant GH response, with peak serum GH levels exceeding 7 ng/ml.
• The five GH-deficient patients showed a blunted response, with peak serum GH levels not exceeding 4 ng/ml.
• The combination of propranolol and exercise demonstrated a clear differentiation between GH-deficient and non-GH-deficient subjects.

Conclusions:

• The combined use of propranolol and exercise is an effective and reliable screening test for evaluating growth hormone (GH) function in children.
• This method enhances GH release, improving diagnostic accuracy compared to exercise stimulation alone.
• The safety and cost-effectiveness of this approach make it a valuable tool in pediatric endocrinology.